{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:58:11Z","timestamp":1793836691664,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Perineural invasion (PNI) is the invasion of nerves by cancer cells and is associated with poor survival in stage II colorectal cancer. However, PNI can be further subdivided according to the depth of invasion, and the depth of PNI has not been clearly linked to prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This study aimed to assess the prognostic value of different depths of PNI in stage II colorectal cancer. We defined PNI in the submucosal plexus and myenteric plexus as superficial perineural invasion (sup-PNI) and PNI in the subserous plexus as deep perineural invasion (deep-PNI). Patients were divided into three groups based on the depth of PNI: sup-PNI, deep-PNI and non-PNI. Then, univariate and multivariate Cox regression analyses were conducted to evaluate the role of PNI in the prognosis of stage II colorectal cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study enrolled 3508 patients with stage II colorectal cancer who underwent resection for primary colorectal lesions between January 2013 and September 2019. Clinicopathological features, including elevated carcinoembryonic antigen (CEA) levels, T4 stage, poor differentiation, deficient DNA mismatch repair (dMMR), and vascular invasion, were correlated with deep-PNI. Multivariate analyses revealed that deep-PNI was associated with worse overall survival (OS; hazard ratio [HR], 3.546; 95% confidence interval [CI], 2.307\u20135.449; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and disease-free survival (DFS; HR, 2.921; 95% CI, 2.032\u20134.198; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), compared with non-PNI. Conversely, no significant difference in OS or DFS was observed between the sup-PNI and non-PNI groups in multivariate analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study demonstrated that the depth of PNI was an independent prognostic factor for patients with stage II colorectal cancer, and patients with deep PNI had a worse prognosis. Thus, patients with PNI require further subdivision according to the depth of invasion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12206-9","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:02:34Z","timestamp":1712584954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"issue":"2","key":"12206_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/gastro\/goab010","volume":"9","author":"Y Xie","year":"2021","unstructured":"Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf). 2021;9(2):91\u2013104.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"12206_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13046-018-0674-x","volume":"37","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the nervous system in cancer metastasis. J Exp Clin Cancer Res. 2018;37(1):5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"12206_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"issue":"8","key":"12206_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","volume":"40","author":"NN Baxter","year":"2022","unstructured":"Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, et al. Adjuvant therapy for stage II colon cancer: ASCO guideline update. J Clin Oncol. 2022;40(8):892\u2013910.","journal-title":"J Clin Oncol"},{"issue":"4","key":"12206_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1245\/s10434-016-5561-0","volume":"24","author":"JA Cienfuegos","year":"2017","unstructured":"Cienfuegos JA, Mart\u00ednez P, Baixauli J, Beorlegui C, Rosenstone S, Sola JJ, Rodr\u00edguez J, Hern\u00e1ndez-Lizo\u00e1in JL. Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I-II colon cancer. Ann Surg Oncol. 2017;24(4):1077\u201384.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"12206_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/DCR.0000000000001258","volume":"62","author":"M Skancke","year":"2019","unstructured":"Skancke M, Arnott SM, Amdur RL, Siegel RS, Obias VJ, Umapathi BA. Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum. 2019;62(2):181\u20138.","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"12206_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/DCR.0000000000002219","volume":"65","author":"YI Kim","year":"2022","unstructured":"Kim YI, Kim CW, Kim JH, Kim J, Ro JS, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, et al. Clinical implication of perineural and lymphovascular invasion in rectal cancer patients who underwent surgery after preoperative chemoradiotherapy. Dis Colon Rectum. 2022;65(11):1325\u201334.","journal-title":"Dis Colon Rectum"},{"issue":"15","key":"12206_CR8","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115(15):3379\u201391.","journal-title":"Cancer"},{"issue":"8","key":"12206_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41575-021-00423-7","volume":"18","author":"L Seguella","year":"2021","unstructured":"Seguella L, Gulbransen BD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):571\u201387.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"12206_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/1078-0432.CCR-12-2392","volume":"19","author":"F Liebl","year":"2013","unstructured":"Liebl F, Demir IE, Rosenberg R, Boldis A, Yildiz E, Kujundzic K, Kehl T, Dischl D, Schuster T, Maak M, et al. The severity of neural invasion is associated with shortened survival in colon cancer. Clin Cancer Res. 2013;19(1):50\u201361.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"12206_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.prp.2015.09.001","volume":"211","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Wang H, Gong H, Cao M, Zhang G, Wang Y. Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pract. 2015;211(11):839\u201344.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"12206_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/DCR.0000000000002339","volume":"66","author":"SS Cho","year":"2023","unstructured":"Cho SS, Park JW, Kang GH, Kim JH, Bae JM, Han SW, Kim TY, Kim MJ, Ryoo SB, Jeong SY, et al. Prognostic impact of extramural lymphatic, vascular, and perineural invasion in stage II colon cancer: a comparison with intramural invasion. Dis Colon Rectum. 2023;66(3):366\u201373.","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"12206_CR13","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/PAS.0b013e318297ef6e","volume":"37","author":"H Ueno","year":"2013","unstructured":"Ueno H, Shirouzu K, Eishi Y, Yamada K, Kusumi T, Kushima R, Ikegami M, Murata A, Okuno K, Sato T, et al. Characterization of perineural invasion as a component of colorectal cancer staging. Am J Surg Pathol. 2013;37(10):1542\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"12206_CR14","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/codi.14994","volume":"22","author":"C Simillis","year":"2020","unstructured":"Simillis C, Singh H, Afxentiou T, Mills S, Warren OJ, Smith JJ, Riddle P, Adamina M, Cunningham D, Tekkis PP. Postoperative chemotherapy improves survival in patients with resected high-risk Stage II colorectal cancer: results of a systematic review and meta-analysis. Colorectal Dis. 2020;22(10):1231\u201344.","journal-title":"Colorectal Dis"},{"key":"12206_CR15","unstructured":"NCCN Guidelines: Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN clinical practice guidelines in oncology: colon cancer. Version 2. 2021. Available at: NCCN.org."},{"key":"12206_CR16","doi-asserted-by":"crossref","unstructured":"Diagnosis, Treatment Guidelines For Colorectal Cancer Working Group C. Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version). Chin J Cancer Res. 2019;31(1):117\u201334.","DOI":"10.21147\/j.issn.1000-9604.2019.01.07"},{"issue":"1","key":"12206_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s12885-023-11114-8","volume":"23","author":"B Zhang","year":"2023","unstructured":"Zhang B, Lin Y, Wang C, Chen Z, Huang T, Chen H, Wang G, Lan P, He X, He X. Combining perineural invasion with staging improve the prognostic accuracy in colorectal cancer: a retrospective cohort study. BMC Cancer. 2023;23(1):675.","journal-title":"BMC Cancer"},{"issue":"1","key":"12206_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/PAS.0000000000000518","volume":"40","author":"N Knijn","year":"2016","unstructured":"Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID. Perineural invasion is a strong prognostic factor in colorectal cancer: a systematic review. Am J Surg Pathol. 2016;40(1):103\u201312.","journal-title":"Am J Surg Pathol"},{"key":"12206_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2021.03.016","volume":"508","author":"JF Zhang","year":"2021","unstructured":"Zhang JF, Tao LY, Yang MW, Xu DP, Jiang SH, Fu XL, Liu DJ, Huo YM, Liu W, Yang JY, et al. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT\/EGR-1\/GDNF axis in pancreatic ductal adenocarcinoma. Cancer Lett. 2021;508:47\u201358.","journal-title":"Cancer Lett"},{"issue":"1","key":"12206_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12094-021-02666-x","volume":"24","author":"Y Lei","year":"2022","unstructured":"Lei Y, He X, Huang H, He Y, Lan J, Yang J, Liu W, Zhang T. Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis. Clin Transl Oncol. 2022;24(1):34\u201347.","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"12206_CR21","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cancers15092623","volume":"15","author":"T Huang","year":"2023","unstructured":"Huang T, Lin Y, Chen J, Hu J, Chen H, Zhang Y, Zhang B, He X. CD51 intracellular domain promotes cancer cell neurotropism through interacting with transcription factor NR4A3 in colorectal cancer. Cancers (Basel). 2023;15(9):2623.","journal-title":"Cancers (Basel)"},{"key":"12206_CR22","doi-asserted-by":"publisher","first-page":"113691","DOI":"10.1016\/j.biopha.2022.113691","volume":"155","author":"Q Liu","year":"2022","unstructured":"Liu Q, Ma Z, Cao Q, Zhao H, Guo Y, Liu T, Li J. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691.","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"12206_CR23","doi-asserted-by":"publisher","first-page":"e19860","DOI":"10.1097\/MD.0000000000019860","volume":"99","author":"G Hu","year":"2020","unstructured":"Hu G, Li L, Hu K. Clinical implications of perineural invasion in patients with colorectal cancer. Medicine (Baltimore). 2020;99(17):e19860.","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"12206_CR24","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","volume":"22","author":"AB Benson 3rd","year":"2004","unstructured":"Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408\u201319.","journal-title":"J Clin Oncol"},{"issue":"16","key":"12206_CR25","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1200\/JCO.2004.03.087","volume":"22","author":"A Figueredo","year":"2004","unstructured":"Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care\u2019s gastrointestinal cancer disease site group. J Clin Oncol. 2004;22(16):3395\u2013407.","journal-title":"J Clin Oncol"},{"issue":"2","key":"12206_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/pin.13195","volume":"72","author":"Y Fukuda","year":"2022","unstructured":"Fukuda Y, Tanaka Y, Eto K, Ukai N, Sonobe S, Takahashi H, Ikegami M, Shimoda M. S100-stained perineural invasion is associated with worse prognosis in stage I\/II colorectal cancer: its possible association with immunosuppression in the tumor. Pathol Int. 2022;72(2):117\u201327.","journal-title":"Pathol Int"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12206-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12206-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12206-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:02:45Z","timestamp":1712584965000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12206-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12206"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12206-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University (2021ZSLYEC-542). All participants have given their informed consent before inclusion. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}